Dr. Scott J. Swanson

Get to Know Dr. Scott J. Swanson

Thoracic surgeon Dr. Scott Swanson treats patients with all types of cancer at Brigham and Women’s Hospital, including lung and esophageal cancer and malignant pleural mesothelioma.

A graduate of Harvard Medical School, Swanson now serves there as chief surgical officer and professor of surgery. He also is part of the International Mesothelioma Program, focused on mesothelioma treatment, and the gastrointestinal program at the Dana-Farber Cancer Institute.

Swanson specializes in minimally invasive surgery, including video-assisted surgery, which helps ease the impact of treatment by reducing post-operative complications and recovery time.

His clinical interests also include thymoma, sarcoma, non-small cell and small cell lung cancer. He has helped produce several educational videos focusing on novel video-assisted surgery.

Close Button

Full Name

Diagnosis Please Select Mesothelioma Asbestosis Lung Cancer Other Unknown

Zip Code

Email

Phone Number

Preferred Method of Contact Please Select Call Text

Message

Full Name

By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Get Connected Now

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Swanson and find the treatment that’s best for you.

Get Started Today

Specialties of Dr. Scott J. Swanson

• Minimally invasive surgery
• Video-assisted surgery
• Thoracic surgery
• Lung cancer
• Esophageal cancer
• Thymic tumors
• Pleural mesothelioma
• Sarcoma

Dr. Scott J. Swanson’s Experience and Education

• Dana-Farber Cancer Institute
• Brigham and Women’s Hospital (Residency and Fellowship)
• Harvard Medical School (M.D.)

Awards and Certifications

• Top Doctors, Boston Magazine
• America’s Top Doctors, Castle Connolly
• Disease center leader, Dana-Farber Cancer Institute thoracic surgery program
• Board certified in surgery and thoracic surgery

Publications of Dr. Scott J. Swanson

• Kandilis, A. et al. (2020, December 12). Residual Lymph Node Disease and Mortality Following Neoadjuvant Chemoradiation and Curative Esophagectomy for Distal Esophageal Adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery.
• Swanson, S.J. (2018, June). Minimally invasive surgery is best treatment for early lung cancer. Journal of Thoracic Disease.
• Veluswamy, R.R. et al. (2015, October). Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology. Journal of Clinical Oncology.